Cargando…
Prognostic significance of MyD88 expression by human epithelial ovarian carcinoma cells
BACKGROUND: MyD88 is an adaptor protein for TLR-4 signaling known to mediate paclitaxel resistance in epithelial ovarian carcinoma (EOC). This study examined the clinical significance of MyD88 expression in EOC. METHODS: MyD88 and TLR-4 expression were examined by immunocytochemistry in 109 specimen...
Autores principales: | Zhu, Yi, Huang, Jian-Ming, Zhang, Guo-Nan, Zha, Xiao, Deng, Bi-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438113/ https://www.ncbi.nlm.nih.gov/pubmed/22533866 http://dx.doi.org/10.1186/1479-5876-10-77 |
Ejemplares similares
-
The MyD88+ Phenotype Is an Adverse Prognostic Factor in Epithelial Ovarian Cancer
por: d'Adhemar, Charles J., et al.
Publicado: (2014) -
Correction: The MyD88+ Phenotype Is an Adverse Prognostic Factor in Epithelial Ovarian Cancer
Publicado: (2014) -
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
por: Silasi, Dan-Arin, et al.
Publicado: (2007) -
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer
por: Block, Matthew S., et al.
Publicado: (2018) -
Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers
por: Kim, Ki Hyung, et al.
Publicado: (2012)